Task: Answer the multiple-choice question.
Question: Which compound exhibits a -11.504% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C(F)F)n2ncc(C(=O)NC3CCCCCC3)c2n1
b: COc1ccc(CN(Cc2cc3cc(OC)c(OC)cc3[nH]c2=O)C(=O)NC2CCCCC2)cc1
Answer: a. Cc1cc(C(F)F)n2ncc(C(=O)NC3CCCCCC3)c2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C(F)F)n2ncc(C(=O)NC3CCCCCC3)c2n1
Cc1cc(C(F)F)n2ncc(C(=O)NC3CCCCCC3)c2n1
N-cycloheptyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide